Namely, we tested the null hypothesis of no difference between healthy controls and ALS against the alternatives of overexpression of benzoic and hexadecanoic acids and TTV in ALS and underexpression of valeric acid, MCP1, and MIP1-α in ALS. This evidence concerns the gene CCL3 and amyotrophic lateral sclerosis.